ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,631.22
0.00%
US Tech 100
19,888.80
0.22%
Dow Jones
40,211.72
0.00%
Brent Oil
83.055
-1.52%
Bitcoin
63,952.63
-1.39%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tempest Therpeutics Inc (TPST)

  7. Tempest Therpeutics Inc (TPST) News

TPST

Tempest Therpeutics (TPST)

Tempest Therpeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TPST
DateTimeSourceHeadlineSymbolCompany
05/29/20225:05AMTipRanksAnalysts Are Bullish on These Healthcare Stocks: Tempest Therapeutics (TPST), Spectrum Pharmaceuticals (SPPI)NASDAQ:TPSTTempest Therpeutics Inc
05/27/20229:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TPSTTempest Therpeutics Inc
05/26/20225:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPSTTempest Therpeutics Inc
05/26/20224:57PMGlobeNewswire Inc.Tempest Reports Positive TPST-1120 Clinical Data from Phase 1 Trial in Patients with Advanced Solid Tumors at 2022 ASCO Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
05/26/20224:15PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TPSTTempest Therpeutics Inc
05/16/20226:13PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:TPSTTempest Therpeutics Inc
05/13/20224:17PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TPSTTempest Therpeutics Inc
05/13/202210:15AMTipRanksTempest Therapeutics (TPST) Gets a Buy Rating from H.C. WainwrightNASDAQ:TPSTTempest Therpeutics Inc
05/13/20228:00AMGlobeNewswire Inc.Tempest Reports First Quarter 2022 Financial Results and Provides Corporate HighlightsNASDAQ:TPSTTempest Therpeutics Inc
05/11/20223:43PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:TPSTTempest Therpeutics Inc
05/09/20228:05AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TPSTTempest Therpeutics Inc
05/09/20228:02AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TPSTTempest Therpeutics Inc
05/03/20225:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPSTTempest Therpeutics Inc
05/03/20225:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPSTTempest Therpeutics Inc
05/03/20225:08PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPSTTempest Therpeutics Inc
05/02/20224:07PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TPSTTempest Therpeutics Inc
05/02/20228:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPSTTempest Therpeutics Inc
04/27/202210:01AMGlobeNewswire Inc.Tempest Announces Oral and Poster Presentations at the Upcoming 2022 ASCO Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
04/27/20228:00AMGlobeNewswire Inc.Tempest Announces Private Placement Financing of $15 MillionNASDAQ:TPSTTempest Therpeutics Inc
04/22/20224:01PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TPSTTempest Therpeutics Inc
04/11/20227:15AMTipRanksH.C. Wainwright Thinks Tempest Therapeutics’ Stock is Going to RecoverNASDAQ:TPSTTempest Therpeutics Inc
04/08/20221:00PMGlobeNewswire Inc.Tempest Presents Promising Preclinical Data on Two Oncology Programs at the 2022 AACR Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
04/01/20226:24AMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:TPSTTempest Therpeutics Inc
03/30/20226:20AMTipRanksH.C. Wainwright Thinks Tempest Therapeutics’ Stock is Going to RecoverNASDAQ:TPSTTempest Therpeutics Inc
03/29/20224:59PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:TPSTTempest Therpeutics Inc
03/29/20224:42PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPSTTempest Therpeutics Inc
03/29/20224:00PMGlobeNewswire Inc.Tempest Reports Year End 2021 Financial Results and Provides Business UpdateNASDAQ:TPSTTempest Therpeutics Inc
03/10/20228:00AMGlobeNewswire Inc.Tempest to Present at the 32nd Annual Oppenheimer Healthcare ConferenceNASDAQ:TPSTTempest Therpeutics Inc
03/08/20224:30PMGlobeNewswire Inc.Tempest to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:TPSTTempest Therpeutics Inc
02/17/20224:20PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TPSTTempest Therpeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TPST

Your Recent History

BIT
UC1H0C
Unicredit Bank
LSE
0LY9
Fabryka Obrabiarek Rafamet
LSE
INTU
Intu Properties
NASDAQ
FBIZ
First Business Financial...
TSXV
HET
LSE
0DGZ
Adolfo Dominguez
BIT
UC8FQX
Unicredit Bank
NYSE
DCP.PRC
DCP Midstream, LP
LSE
MI88
Citi Fun 25
NASDAQ
LOCO
El Pollo Loco
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved